Kazia Therapeutics (KZIA) Interest Coverage Ratio (2009 - 2016)

Kazia Therapeutics (KZIA) posted Interest Coverage Ratio of 76.04 for Q4 2016, down 4656.68% on a QoQ basis from 1.6 in Q4 2013.

Kazia Therapeutics (KZIA) Interest Coverage Ratio (2009 - 2016) Analysis & Trends

Kazia Therapeutics' Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 76.04 for Q4 2016.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 76.04 in Q4 2016, while the trailing twelve-month figure through Jun 2017 was 2.7057390946528592e+17 (up 45.36% YoY) and the FY2017 annual result came in at 12.95, changed N/A from the prior year.
Interest Coverage Ratio was 76.04 for Q4 2016 at Kazia Therapeutics, down from 1.6 in the prior quarter.
Across five years, Interest Coverage Ratio topped out at 1.6 in Q4 2013 and bottomed at 76.04 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	658.42
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	7.60
4	NuCana	279.75 Bn	279.75 Bn	-	-0.22
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	22.72
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-0.38
10	Kazia Therapeutics	4.11 Mn	4.11 Mn	-	-

Download Data